New counterfeit report highlights worrying trends
"Today, few jurisdictions, whether developed or developing, are immune from counterfeit pharmaceuticals and the infringement of intellectual property rights", warned the report on counterfeiting released by the Organisation for Economic Co-operation and Development (OECD).
While the magnitude of counterfeit pharmaceuticals is still reported as low (less than one percent) in many developed countries, such as Australia, Canada, the EU, Japan, New Zealand and the US, they are becoming increasingly affected as the practice of global sourcing and manufacturing intensifies.
By Kirsty Barnes
7 November 2007